Literature DB >> 25262720

Pancreatic neuroendocrine tumor with extensive intraductal invasion of the main pancreatic duct: a case report.

Maki Kiyonaga1, Shunro Matsumoto, Hiromu Mori, Yasunari Yamada, Ryo Takaji, Naoki Hijiya, Fumitaka Yoshizumi, Masanori Aramaki.   

Abstract

CONTEXT: Pancreatic neuroendocrine tumors account for only 1-3% of all pancreatic neoplasms and the intraductal invasion of the main pancreatic duct (MPD) is rare. CASE REPORT: We report a case of a 26-year-old woman with an endocrine tumor of the pancreas extensively invading into the MPD. She presented abdominal pain and her laboratory data showed abnormal liver function. Contrast-enhanced computed tomography demonstrated a well-enhanced mass on the arterial dominant phase in the head of the pancreas. The mass grew within the lumen of the MPD in the body of the pancreas, with dilatation of the upstream MPD. The contrast-enhancement pattern between the main tumor of the head and the intraductal lesion of the body was different. On T2-weighted magnetic resonance (MR) imaging, the pancreatic head lesion showed non homogeneously low signal intensity, while the intraductal lesion of the pancreatic body showed high signal intensity. MR cholangiopancreatography showed obstruction of the MPD in the pancreatic head to body, with dilatation of the upstream MPD. An endocrine tumor or acinar cell carcinoma of the pancreas was considered as preoperative diagnosis, and pancreaticoduodenectomy was performed. As a result, pancreatic endocrine tumor (G2) was confirmed pathologically.
CONCLUSION: A rare case of pancreatic neuroendocrine tumor with extensive growth within the MPD was presented. The intraductal extension is a unique growth pattern of nonfunctioning pancreatic neuroendocrine tumor, and the desmoplastic reaction in this tumor may reflect the increased invasiveness.

Entities:  

Year:  2014        PMID: 25262720     DOI: 10.6092/1590-8577/2741

Source DB:  PubMed          Journal:  JOP        ISSN: 1590-8577


  4 in total

1.  Serotonin immunoreactive pancreatic neuroendocrine neoplasm associated with main pancreatic duct dilation: a recognizable entity with excellent long-term outcome.

Authors:  Marco Dioguardi Burgio; Jérome Cros; Nicola Panvini; Thomas Depoilly; Anne Couvelard; Philippe Ruszniewski; Louis de Mestier; Olivia Hentic; Alain Sauvanet; Safi Dokmak; Alex Faccinetto; Maxime Ronot; Valérie Vilgrain
Journal:  Eur Radiol       Date:  2021-05-11       Impact factor: 5.315

2.  Intraductal Tubulopapillary Neoplasm of the Pancreas: A Clinicopathologic and Immunohistochemical Analysis of 33 Cases.

Authors:  Olca Basturk; Volkan Adsay; Gokce Askan; Deepti Dhall; Giuseppe Zamboni; Michio Shimizu; Karina Cymes; Fatima Carneiro; Serdar Balci; Carlie Sigel; Michelle D Reid; Irene Esposito; Helena Baldaia; Peter Allen; Günter Klöppel; David S Klimstra
Journal:  Am J Surg Pathol       Date:  2017-03       Impact factor: 6.394

3.  Natural History of Pancreatic Duct Obstruction by a Pancreatic Neuroendocrine Tumor.

Authors:  Alexander S Thomas; Lyndon Luk; John A Chabot
Journal:  J Gastrointest Surg       Date:  2022-01-26       Impact factor: 3.452

4.  Pancreatic Neuroendocrine Neoplasm Invading the Entire Main Pancreatic Duct Diagnosed by a Preoperative Endoscopic Biopsy.

Authors:  Tomoya Kimura; Mitsuru Sugimoto; Tadayuki Takagi; Rei Suzuki; Naoki Konno; Hiroyuki Asama; Yuki Sato; Hiroki Irie; Jun Nakamura; Mika Takasumi; Minami Hashimoto; Tsunetaka Kato; Yasuhide Kofunato; Takashi Kimura; Shoki Yamada; Yuko Hashimoto; Shigeru Marubashi; Takuto Hikichi; Hiromasa Ohira
Journal:  Intern Med       Date:  2020-05-23       Impact factor: 1.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.